Literature DB >> 20119568

Improved functioning in children diagnosed with reactive attachment disorder after SSRI therapy.

Harvey A Weinberg1.   

Abstract

Entities:  

Year:  2010        PMID： 20119568      PMCID： PMC2809447     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN： 1719-8429


× No keyword cloud information.
  7 in total

Review 1.  Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models.

Authors:  M M Sánchez; C O Ladd; P M Plotsky
Journal:  Dev Psychopathol       Date:  2001

2.  Emotion understanding in postinstitutionalized Eastern European children.

Authors:  Alison B Wismer Fries; Seth D Pollak
Journal:  Dev Psychopathol       Date:  2004

3.  2008 position paper on using SSRIs in children and adolescents.

Authors:  E Jane Garland; Stan Kutcher; Adil Virani
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-05

4.  Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior.

Authors:  Alison B Wismer Fries; Toni E Ziegler; Joseph R Kurian; Steve Jacoris; Seth D Pollak
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-22       Impact factor: 11.205

5.  Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C receptors.

Authors:  L M Katz; L Nathan; C M Kuhn; S M Schanberg
Journal:  Psychoneuroendocrinology       Date:  1996-02       Impact factor: 4.905

6.  Growth retardation and emotional deprivation: relative resistance to treatment with human growth hormone.

Authors:  S D Frasier; M L Rallison
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

Review 7.  Risk and resilience: early manipulation of macaque social experience and persistent behavioral and neurophysiological outcomes.

Authors:  Hanna E Stevens; James F Leckman; Jeremy D Coplan; Stephen J Suomi
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-02       Impact factor: 8.829
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.